Implanet S.A. (EPA:ALIMP)
0.1935
-0.0055 (-2.76%)
At close: Nov 28, 2025
Implanet Company Description
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally.
The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fixation.
It also provides ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. The company exports its products.
Implanet S.A. was founded in 2006 and is headquartered in Martillac, France.
Implanet S.A.

| Country | France |
| Founded | 2006 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 46 |
| CEO | Ludovic Lastennet |
Contact Details
Address: Technopole Bordeaux Montesquieu Martillac, 33650 France | |
| Phone | 33 5 57 99 55 55 |
| Website | implanet.com |
Stock Details
| Ticker Symbol | ALIMP |
| Exchange | Euronext Paris |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0013470168 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Ludovic Lastennet | Chief Executive Officer, Commercial Director and Director |
| David Dieumegard | Vice President of Financial |
| Yvanna Peigne | Operations Manager |
| Benjamin Letienne | Vice President of Marketing and International Sales and Director |